No PMDD treatment has been shown to be best for everyone. A 2025 network meta-analysis concluded that both SSRIs and combined oral contraceptives are effective for premenstrual dysphoric disorder, but it rested on only five studies, and its authors say direct comparative trials between the two classes are still needed. [berni-2025] This guide covers what the main reviews found for each option, where they disagree, what they could not show and how to use that in a conversation with a doctor. Our overview of PMDD covers the condition itself.
What are the main treatments for PMDD?
There are three families, and the evidence behind them is very uneven. SSRIs, a type of antidepressant, are described in the 2025 review’s introduction as the first choice for treatment, and combined oral contraceptives as the main hormonal option, which works by suppressing ovulation. [berni-2025] Psychological therapy, mainly cognitive behavioural therapy (CBT), is the third, with a much thinner evidence base in the review we could verify. [lustyk-2009]
This guide compares them. For the SSRI evidence on its own, including dosing schedules, see PMDD and SSRIs: what the evidence shows.
Do antidepressants or birth control work better for PMDD?
The evidence cannot yet say, though one network meta-analysis points to a leader in each group. It included 16 studies, of which five were combined in the network analysis. Continuous paroxetine showed the greatest effect across all the symptom domains it analysed, and a drospirenone and ethinyl estradiol pill taken on a 24/4 schedule (24 active tablets, then 4 inactive) was the most effective contraceptive regimen. [berni-2025]
The authors’ conclusion was that both SSRIs and combined oral contraceptives are effective, and that the choice should consider predominant symptom patterns, individual tolerability and reproductive planning. They also wrote that further direct comparative trials between the classes are needed. [berni-2025]
| Option | What the reviews found | Main limit stated |
|---|---|---|
| SSRIs (continuous paroxetine) | Greatest effect across symptom domains in a 2025 network meta-analysis | Network rested mostly on one study per comparison |
| Combined oral contraceptives | Better than placebo for overall symptoms in a 2021 meta-analysis of 9 trials | Not clearly better than placebo for depressive symptoms |
| Cognitive behavioural therapy | Little statistically significant evidence in a 2009 review of 7 studies | The review is from 2009 and cannot cover later trials |
Do birth control pills help PMDD?
They probably help overall premenstrual symptoms, but the evidence does not show they help depressive symptoms specifically. A 2021 meta-analysis pooled 9 randomised trials that studied 1,205 women with premenstrual syndrome or PMDD, measuring change from baseline to three cycles. Combined oral contraceptives beat placebo for overall premenstrual symptoms (standardised mean difference 0.41, 95% credible interval 0.17 to 0.67) but not for depressive symptoms (0.22, interval -0.06 to 0.47). [de-wit-2021]
A standardised mean difference puts different symptom scales on one footing, in units of standard deviation. On the conventional benchmarks, where 0.2 is called small and 0.5 medium, 0.41 sits between the two. That reading is the general convention and not a judgement the authors make. The interval for depressive symptoms includes zero, which means that study could not rule out no benefit for mood.
Standardised mean differences for combined oral contraceptives versus placebo, de Wit et al. (2021), 9 trials in 1,205 women with premenstrual syndrome or PMDD. The interval for depressive symptoms (-0.06 to 0.47) includes zero.
The same review found that none of the combined oral contraceptives was more effective than another, for either outcome. [de-wit-2021] The 2025 network meta-analysis ranked one regimen first, as above. The two do not agree, and the 2025 comparison rested on far fewer studies, so the 24/4 finding is a lead worth discussing and not a settled ranking. [berni-2025]
The introduction of the 2025 review also records two cautions drawn from other work: that contraceptive pills may worsen mood in people with a previous psychiatric diagnosis, and that they are not considered a suitable option for those planning pregnancy. [berni-2025] Both are reasons to raise your history with a doctor before starting, not reasons to rule the option out.
Does therapy help PMDD?
The best systematic review we could verify found little statistically significant evidence for CBT, and it is from 2009. It identified seven studies, three of them randomised controlled trials, whose methods varied widely. The authors described a dearth of evidence for statistically significant intervention effects, and called for more rigorous trials of psychological approaches. [lustyk-2009]
That finding is easy to over-read in either direction. It is not evidence that therapy does not work: more trials have been published in the years since, and this guide has not reviewed them. It is also not evidence that therapy works. What it supports is a narrower point: when this review was written, the research base for CBT in premenstrual disorders was thin.
What can these reviews not tell you?
They cannot tell you which treatment will work for you, and they cannot rank the options with confidence. Five limits matter most:
- The SSRI and pill comparison is indirect. The 2025 network combines separate trials of each class. The authors call for direct comparative trials between them. [berni-2025]
- The network was small. Only five studies went into it, and most comparisons rested on a single study per node, which the authors say reduced its statistical robustness. [berni-2025]
- The 2021 pill meta-analysis covers PMS as well as PMDD. It included women with premenstrual syndrome or PMDD, so its figures are not for PMDD alone. [de-wit-2021]
- Mood outcomes are separate from overall outcomes. A pill that improves overall symptoms may still leave low mood unchanged, as the 2021 interval shows. [de-wit-2021]
- The therapy evidence is dated. The CBT review is from 2009, so it cannot cover anything published since. [lustyk-2009]
How do you choose between PMDD treatments?
Choose with a doctor, using your own symptom pattern, your history and your plans, because that is what the 2025 authors say the decision should rest on. [berni-2025] The rest of this section is our suggestion and is not something the reviews tested.
Two cycles of daily symptom records are the most useful thing to bring: which symptoms dominate (irritability, low mood, physical symptoms), when they start and stop, and what you have already tried. Alongside it, bring three facts the reviews name as relevant: whether you want contraception, whether you plan a pregnancy, and whether you have had a mood or anxiety diagnosis before. Our guide to how PMDD is diagnosed explains why the record matters, and PMDD versus PMS covers where the line falls.
No screener on this site covers PMDD yet. The self-assessment hub lists the seven we do have, and none is built for this question.
When to seek help
Speak to a doctor if your mood changes in the days before a period are disrupting work, relationships or your safety, rather than waiting to decide on a treatment yourself. Do not start or stop a medication or a contraceptive pill without medical advice. If you feel unable to keep yourself safe, contact your local emergency services or a crisis helpline.
How MyFreud can help
A treatment conversation goes better with a record than with a description. Daily mood tracking in MyFreud shows how your days run across a cycle, and the notepad is somewhere to log sleep, irritability and what you tried next to how the day went. It does not replace a doctor.
Download MyFreud and start today: App Store or Google Play.